HB1968Enacted

Amends TCA Title 20 and Title 33.

Tennessee HB1968 amends Title 20 and Title 33 of the Tennessee Code Annotated by adding Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that the attorney general may release from liability for pending or future claims related to opioids. This bill affects these pharmaceutical companies by potentially absolving them of certain legal claims associated with opioid-related issues. The key provision is the inclusion of these companies in the list eligible for release from such claims.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee HB1968 amends Title 20 and Title 33 of the Tennessee Code Annotated by adding Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that the attorney general may release from liability for pending or future claims related to opioids. This bill affects these pharmaceutical companies by potentially absolving them of certain legal claims associated with opioid-related issues. The key provision is the inclusion of these companies in the list eligible for release from such claims.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Farmer, Andrew

Details
Session

114th General Assembly

Introduced

January 22, 2026

Last Action

May 18, 2026

Comp. became Pub. Ch. 888

Subjects
Opioids

Want to track this bill? Get instant alerts and AI-powered insights.

HB1968: Amends TCA Title 20 and Title 33. | LegisGo